← Open Payments lookup

KATIE WALLACE: Open Payments

NPI 1952703092 · BURLINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$484 in 21 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $99 · 2025 $484

Food & beverage: $484
CompanyPaymentsAmount
UCB, Inc.7$200
Amgen Inc.4$109
GENZYME CORPORATION2$42
Galderma Laboratories, L.P.2$34
Organon LLC1$22
Lilly USA, LLC1$18
Regeneron Healthcare Solutions, Inc.1$17
ABBVIE INC.1$14
Arcutis Biotherapeutics, Inc.1$14
E.R. Squibb & Sons, L.L.C.1$13

Products named: Bimzelx, Otezla, DUPIXENT, NEMLUVIO, VTAMA, TALTZ, SKYRIZI, Zoryve.

Industry payments across MA — which companies pay providers there.